Scholars Central

EditorialPublished 2012

High Active Anti-retroviral Therapy for HIV/AIDS, Progresses and Drawback

Authors: Da-Yong Lu, Ting-Ren Lu

Advances in Pharmacoepidemiology and Drug Safety

Volume 1 · Issue 6 · Pages 1–3

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

AIDS (acquired immune deficient syndrome) is a human infectious disease. AIDS patients, if not be treated, commonly suffer a gradual loss of human immune-defensive functions and finally die of infectious complications within 2 years after AIDS symptoms occur in patients. AIDS patients can be treated with a series of anti-viral drugs to decrease the virus-load and slow the pace of occurrence AIDS and ameliorate the symptoms of immune deficient and prolong the life-spans of patients by high active anti-retroviral therapy (HAART). Even though HAART is very effective, HIV/AIDS patients cannot be cured by HAART. And there are a lot of precautious for this therapy. There are a plethora of reasons behind these phenomena. In this review, we will detail address this problem and try to give new directions.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Advances in Pharmacoepidemiology and Drug Safety.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalAdvances in Pharmacoepidemiology and Drug Safety
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Da-Yong Lu”
  • BylineArticles whose byline prints “Ting-Ren Lu”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels